Analysis of Blood Typing, Grouping and Screening Tests, and Strategic Profiles of Leading Suppliers

September 2012 | 225 pages | ID: A40014EE241EN
Venture Planning Group

Abstracts

This 225-page report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 225 pages and 6 tables

Contents

1. BLOOD TYPING AND GROUPING TESTS

a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups

2. INFECTIOUS DISEASE SCREENING TESTS

a. AIDS
    Structure and Composition
    Classification
    Origin of AIDS
    Animal Lentivirus Systems
    Virus Receptors
    HIV Infections in Humans
      Pathogenesis & Pathology
      Overview of Course of HIV Infection
    CD4T Lymphocytes and Memory Cells
    Monocytes and Macrophages
    Lymphoid Organs
    Neural Cells
    Viral Coinfections
      Clinical Findings
    Plasma Viral Load
    Pediactric AIDS
      Neurologic Disease
      Opportunistic Infections
      Protozoa
      Fungi
      Bacteria
    Viruses
    Cancer
    Immunity
    Laboratory Diagnosis
      Virus Isolation
      Serology
      Detection of Viral Nucleic Acid or Antigens
    Epidemiology
      Worldwide Spread of AIDS
      United States
      Routes of Transmission
    Prevention, Treatment, And Control
      Antiviral Drugs
      Vaccines Against HIV
    Transmission of HIV in Blood Products
    HIV Transmission in Transplant and Artificial Insemination Recipients
    Diagnostic Tests
    Enzyme Immunoassay Interpretation
    Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay
    Competition Assays
    Western Blot Technique
    Immuno-Fluorescence Assay (IFA)
    Radioimmunoprecipitation
    HIV-1/HIV-2 Combination Testing
    Methods of HIV-Antigen Detection
    Antigen Assays and Blood Screening
    Urine Tests
    DNA Probes
    Overview
    Quantitative Polymerase Chain Reaction
    In Situ PCR
    Needed Improvements
    Viral Load/Drug Resistance Testing
    Genotype and Phenotype Testing
    Blood Banking Considerations
b. Hepatitis
    Hepatitis A
    Hepatitis B
      Structure and Composition
      Replication of Hepatitis B Virus
    Hepatitis C
    Hepatitis D (Delta Hepatitis)
    Hepatitis E
    Hepatitis G
    Hepatitis Virus Infections In Humans
      Pathology
    Clinical Findings
    Laboratory Features
      Hepatitis A
      Hepatitis B
      Hepatitis C
      Hepatitis D
      Hepatitis E
    Virus-Host Immune Reactions
    Epidemiology
      Hepatitis A
      Hepatitis B
      Hepatitis C
      Hepatitis D (Delta Agent)
    Vaccines and Drugs
c. Cytomegalovirus
    Background
    Chorioretinitis
    Gastrointestinal
    Central Nervous System Disease
    Diagnostic Tests
    Vaccines and Drugs
d. Syphilis
    Background
    Diagnostic Tests
    Vaccines and Drugs
e. West Nile Virus
    Background
    Clinical Syndromes
    Diagnostic Tests
    Vaccines and Drugs
f. Parvovirus B19
    Microbiology
    Epidemiology
    Clinical Syndromes
      Erythema Infectiosum Slapped (cheek)
      Adult Polyarthropathy
      Transient Aplastic Crisis
      Transient Pancytopenia
      Red Cell Aplasia in the Immunocompromised
      Perinatal Infections
    Diagnosis
    Treatment
g. Creutzfeldt-Jakob’s Disease
    Background
    Transmission
    Diagnostic Tests
    Major Commercial and Academic Players
      Bayer
      Disease Sciences/BioTec Global
      Imperial College School of Medicine
      Ortho-Clinical Diagnostics
      Pall
      ProMetic Life Sciences
      Proteome Sciences/Idexx
      Q-One Biotech
      Serono
      U.S. Agricultural Research Service
    Drugs
    Vaccines
h. Malaria
i. Chagas Disease
j. Babesiosis

3. PATHOGEN REDUCTION

4. LEUKOCYTE REDUCTION

    Background
    Methods

COMPETITIVE ASSESSMENTS

    Abbott
    Beckman Coulter/Danaher
    Becton Dickinson
    Biokit
    BioMerieux
    Bio-Rad
    Diagast
    DiaSorin
    Fujirebio
    Gen-Probe
    Grifols
    Immucor
    Innogenetics
    Ortho-Clinical Diagnostics
    Orchid CellMark
    Novartis Diagnostics
    Proteome Sciences
    Roche
    Siemens
    Tecan

List Of Figures

LIST OF FIGURES

Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests